University of Pittsburgh Medical Center

Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update

Retrieved on: 
목요일, 11월 2, 2023
Science, Neoplasm, Patient, FDA, Gemcitabine, Progression-free survival, Biomarker, FOLFIRI, Oregon Health & Science University, PLK1, Knight Cancer Institute, Oregon Health and Science University Center for Women's Health, Clinical uses of mesenchymal stem cells, Pfizer, Cancer, OHSU, University of Pittsburgh Medical Center, CRDF, PT, SAN, ORR, University, SOC, Safety, Dicarboxylic acid, Investment, PR, Pharmaceutical industry, Cryptocurrency

"This has been a transformational quarter for Cardiff Oncology.

Key Points: 
  • "This has been a transformational quarter for Cardiff Oncology.
  • Contingent upon the results of CRDF-004, Cardiff Oncology plans to initiate CRDF-005, a Phase 3, randomized trial with registrational intent.
  • As of September 30, 2023, Cardiff Oncology had approximately $81.4 million in cash, cash equivalents, and short-term investments.
  • Cardiff Oncology will host a corresponding conference call and live webcast at 4:30 p.m. ET/1:30 p.m. PT on November 2, 2023.

Dynami Funds New Groundbreaking Research for Lobular Breast Cancer

Retrieved on: 
수요일, 11월 1, 2023
Dean (education), Karmanos Cancer Institute, Biomarker, Leigh, Doctor of Philosophy, Disease, Risk, Partnership, DRS, University of Michigan, UPMC, Fertility preservation, Hope, Physician, Hereditary lobular breast cancer, Impact, University of Pittsburgh Medical Center, IVF, Breast cancer, University, Morávek, Cancer, Patient, Biomedical engineering, ILC, University of Colorado, History, MD, Work, Woman, University of Colorado School of Medicine, Black, Multimedia, Recurrence, Personalized medicine, United States and Canadian Academy of Pathology, Medical device, Vaccine, Medical imaging, Birth control, Pharmaceutical industry, Research, Pathology, Pharmacology, Dynamy

DETROIT, Nov. 1, 2023 /PRNewswire/ -- The Dynami Foundation has funded groundbreaking new research and support for lobular breast cancer through their partnership with University of Michigan Health. Recently released University of Michigan Health Impact Report outlines the progress and work made possible by the Dynami Foundation's initiatives that are focused on transforming the future of invasive lobular breast cancer (ILC) through the funding of research.

Key Points: 
  • DETROIT, Nov. 1, 2023 /PRNewswire/ -- The Dynami Foundation has funded groundbreaking new research and support for lobular breast cancer through their partnership with University of Michigan Health.
  • From groundbreaking new research on circulating cells to a dual-institution effort to combat cancer, Dynami and University of Michigan have partnered to drive progress.
  • A patient-centered decision-making process by understanding goals of lobular breast cancer patients for an elevated, personalized breast reconstruction experience led by Dr. Paige Myers.
  • Dynami has funded over 12 research projects and will continue to fight for advancement for lobular breast cancer just like the incredible work and impact that we've made here."

NEC OncoImmunity publishes research using its neoantigen prediction technology showing improved outcome in sarcoma patients treated with cancer immunotherapy

Retrieved on: 
화요일, 10월 17, 2023
Software, Research, Pharmaceutical, Oncology, Technology, Artificial Intelligence, Health Technology, Clinical Trials, Science, Biotechnology, Other Science, Health, Neoplasm, Professor, Cancer, Sarcoma, Frontiers, Biomarker, University of Pittsburgh Medical Center, NEC, AI, OUH, University, Artificial intelligence, Oslo University Hospital, PFS, Monroe Dunaway Anderson, Blood, University of Bergen, Patient, NOI, Medical imaging, Immunology

The authors sequenced tumor samples and blood from patients who participated in the pivotal SARC028 clinical trial and received the pembrolizumab checkpoint inhibition therapy.

Key Points: 
  • The authors sequenced tumor samples and blood from patients who participated in the pivotal SARC028 clinical trial and received the pembrolizumab checkpoint inhibition therapy.
  • They then used their AI-based neoantigen prediction technology, the NEC Immune Profiler, to investigate whether high quality neoantigens in cooperation with the immune cell composition in the tumor improved PFS.
  • The NOI researchers believe that AI can play a future role in guiding future personalized medicine and cancer diagnostics, ultimately improving outcomes for patients with cancer.
  • These and future advances in this field may lead to improved clinical outcome for patients suffering from rare cancers treated with cancer immunotherapy,” said Dr. Trevor Clancy, Chief Scientific Officer at NEC OncoImmunity, and a senior author in the study.

Karius Test® Improves the Diagnosis and Management of Pneumonia in Patients Undergoing Treatment for Blood Cancer

Retrieved on: 
화요일, 10월 10, 2023
Research, Infectious Diseases, Genetics, Clinical Trials, Biotechnology, Other Health, Health, Science, Oncology, Diagnosis, Memorial Sloan Kettering Cancer Center, University of Pittsburgh Medical Center, Immunodeficiency, Fred Hutchinson Cancer Research Center, Death, Plasma, DNA, The Study, Risk, National Cancer Institute, Weill Cornell Medicine, University, Loris Karius, MD Anderson Cancer Center, University of Colorado Denver, Principal, University of California, Detection, City, University of Colorado, Bone marrow, Publication, Infection, Bronchoscopy, Duke University Health System, Metagenomics, Patient, Vaccine, Pharmaceutical industry, Pneumonia

“Often clinicians must weigh the risks of invasive procedures in medically fragile patients with an anticipated low diagnostic yield.

Key Points: 
  • “Often clinicians must weigh the risks of invasive procedures in medically fragile patients with an anticipated low diagnostic yield.
  • Identifying the specific cause of pneumonia in patients with blood cancers who are often severely immunocompromised is difficult and critically important to successful treatment.
  • “This well-designed clinical trial conducted at leading academic centers shows that the Karius Test is highly valuable in immunocompromised patients with suspected infection,” said Dr. Ned Sharpless, former Director, National Cancer Institute, and newest Karius board member.
  • “These patients have much to gain through an improved etiologic diagnosis, and the better and more directed treatment of these infections that make this possible,” said Brad Perkins, Chief Medical Officer at Karius.

Julie Zweig, MD, Integrative Sleep & ENT Is Now Offering Wellness And Health Coaching From Mimi Ellis PA-C, RDN, CHC.

Retrieved on: 
금요일, 10월 13, 2023
Food, Health, Multimedia, Knowledge, Emory University School of Medicine, National Society, Insulin resistance, Weight loss, MD, Self-control, Hearing, University, University of Pittsburgh Medical Center, Hormone, Otorhinolaryngology, RDN, Body image, Sleep, Overalls, General surgery, ENT, Suite, Patient, CHC, Nursing, Pharmaceutical industry, Atlanta metropolitan area

ALPHARETTA, Ga., Oct. 13, 2023 /PRNewswire-PRWeb/ -- Julie Zweig, MD, Integrative Sleep & ENT in Alpharetta, GA, is now offering wellness and health coaching from Mimi Ellis PA-C, RDN, CHC, a renowned registered dietitian and certified health coach. Ms. Ellis brings her extensive knowledge and experience to help patients achieve their wellness goals at Julie Zweig, MD Integrative Sleep & ENT where she teaches an intuitive eating / non-diet method to nutrition and has practiced this approach herself for over thirty years. With a focus on intuitive eating and developing a healthy relationship with food, in conjunction with lifestyle changes, patients can look forward to achieving sustainable results. Intuitive eating is a revolutionary method that focuses on listening to the body's natural cues and signals to guide eating habits for physical reliance rather than emotional eating. Her approach to nutrition is from a place of self-care, not self-control, and she doesn't believe in the restriction of food. She understands the challenges and frustrations of yo-yo dieting, weight struggles and body image obsession. One of the key areas where Ms. Ellis' guidance can make a significant impact is weight management. Using her unique approach, she can assist patients who are prescribed drugs for weight loss, as well as those using medications to address insulin resistance, such as Ozempic, Wegovy and Rybelsus, to achieve their desired goals and also maintain them after the use of these medications. Julie Zweig Integrative Sleep & ENT Clinic believes that continuing a healthy lifestyle is crucial, even after patients stop using weight loss drugs or insulin resistance medications. Ms. Ellis' guidance empowers patients to continue their journey towards improved health and wellness, ensuring the long-term benefits of these medications are sustained. Mimi Ellis started her healthcare career in 1993 as a registered dietitian, then continued to become a physician assistant (PA). She has been a practicing PA ever since, working in general surgery, ob/gyn and with Dr. Zweig in otolaryngology since 2013, and she also became a certified health coach in 2020 through the National Society of Health Coaches. Ms. Ellis offers a mix of online group courses, customizable digital meal plans, individual counseling, coaching and virtual sessions.

Key Points: 
  • Serving the Greater Atlanta, GA, area, Julie Zweig, MD Integrative Sleep & ENT promotes overall wellness and optimal health now with coaching from Mimi Ellis, PA-C, RDN, CHC.
  • ALPHARETTA, Ga., Oct. 13, 2023 /PRNewswire-PRWeb/ -- Julie Zweig, MD, Integrative Sleep & ENT in Alpharetta, GA, is now offering wellness and health coaching from Mimi Ellis PA-C, RDN, CHC , a renowned registered dietitian and certified health coach.
  • More about Julie Zweig, MD Integrative Sleep & ENT:
    Julie Zweig, MD Integrative Sleep & ENT is located at 2650 Holcomb Bridge Road, Suite 510 in Alpharetta, Georgia.
  • Dr. Julie Zweig, Julie Zweig, MD Integrative Sleep & ENT, 404-255-4080, [email protected] , https://juliezweigmd.com/
    View original content to download multimedia: https://www.prweb.com/releases/julie-zweig-md-integrative-sleep--ent-is-...

New Facility Planned for BayCare's St. Joseph's Children's Hospital

Retrieved on: 
수요일, 10월 4, 2023
Central Florida, University, St. Joseph's Hospital, Teaching, Research, Child, Conners, Hospital, Patient, Investment, Physician, Love, BayCare Ballpark, University of Pittsburgh Medical Center, Health, ST, Trauma, Environment, BC Children's Hospital Foundation, Nursing

TAMPA, Fla., Oct. 4, 2023 /PRNewswire/ -- BayCare, West Central Florida's leading health care system, announced today that it is planning to build a new, specially designed facility for St. Joseph's Children's Hospital in Tampa by 2030 as part of a strategic effort to increase the region's access to high-quality, state-of-the-art pediatric health care. 

Key Points: 
  • BayCare is the region's largest provider of pediatric services and St. Joseph's Children's Hospital (SJCH) is its largest-volume pediatric hospital.
  • The Tampa hospital also is home to St. Joseph's Children's Hospital Steinbrenner Emergency/Trauma Center with the region's largest team of board-certified pediatric emergency physicians.
  • A new SJCH facility would be the fourth new hospital project BayCare has undertaken in the past five years.
  • BayCare opened its 16th hospital, BayCare Hospital Wesley Chapel, in March 2023 and will open a replacement facility for South Florida Baptist Hospital in Plant City in early 2024.

Dr. Laura M. Tiedemann, Esteemed Oculoplastics Surgeon, Joins OCLI Vision's Growing Team

Retrieved on: 
금요일, 9월 29, 2023
Columbia University, Blepharoplasty, Bachelor of Science in Human Biology, University, Spanish National Health System, Boston Children's Hospital, George Washington University School of Medicine & Health Sciences, Orbit (anatomy), University of Pittsburgh Medical Center, Ophthalmology, Author, Research, Learning, NYU Langone Health, New York Medical College, Child, MD, Patient, Brown University, Internal medicine, Outline of health sciences, Spectrum, Hospital, Health, Yale New Haven Hospital, Filler (linguistics), Westchester Medical Center, Family, Dentistry, Nursing, Science, Neuroscience

GARDEN CITY, N.Y., Sept. 29, 2023 /PRNewswire-PRWeb/ -- OCLI Vision is proud to welcome Laura M. Tiedemann, MD, to their esteemed team of ophthalmologists. Dr. Tiedemann is a highly skilled and compassionate oculoplastics surgeon who brings her extensive expertise and dedication to patient care to the OCLI family. "As a New Jersey native, I am excited to join OCLI Vision and return to the tri-state area," Dr. Tiedemann shared. "Providing exceptional care to my patients has always been a passion of mine, and I am eager to make a meaningful impact on the eye health of my community."

Key Points: 
  • Esteemed oculoplastics surgeon Dr. Laura M. Tiedemann has joined OCLI Vision, specializing in minimally invasive cosmetic and reconstructive eye treatments.
  • GARDEN CITY, N.Y., Sept. 29, 2023 /PRNewswire-PRWeb/ -- OCLI Vision is proud to welcome Laura M. Tiedemann, MD, to their esteemed team of ophthalmologists.
  • Dr. Tiedemann is a highly skilled and compassionate oculoplastics surgeon who brings her extensive expertise and dedication to patient care to the OCLI family.
  • "As a New Jersey native, I am excited to join OCLI Vision and return to the tri-state area," Dr. Tiedemann shared.

NICO Awards $50,000 Grant to Better Understand the Biological Weakness of Rare Chordoma Tumors

Retrieved on: 
목요일, 9월 21, 2023
University, Chordoma, APS, Crystal skull, Spinal cord, Survival, Cancer, Quality of life, Spine, Hope, IIS, Research, Artery, MS, PDX, DSM-IV codes, University of Pittsburgh Medical Center, NICO, Neurosurgery, Patient, Physician, MIPS, Growth, UPMC, Neoplasm, Recurrence, Environment, Disease, Pharmaceutical industry, Medical imaging, Dentistry, MD

INDIANAPOLIS, Sept. 21, 2023 /PRNewswire/ -- Zachary C. Gersey, MD, MS, neurosurgery resident at the University of Pittsburgh Medical Center, has been awarded a $50,000 Investigator Initiated Study (IIS) grant from NICO Corporation. The study aims to determine if immediate biological preservation of patient-derived chordoma tumor tissue, collected intraoperatively and implanted for serial sampling in translational research, will provide new insights into the biological weakness of the disease and contribute to developing improved treatment therapies.

Key Points: 
  • If we are able to further understand the drivers for chordoma recurrence, we may be able to treat recurrences better.
  • The technologies together enable freshly resected chordoma tissue to be harvested and immediately implanted into hosts to study the molecular characteristics of chordoma regrowth in a controlled setting.
  • The goal is to develop a working chordoma PDX model using tissue obtained from NICO technologies.
  • "The pressing need remains for better treatments for chordoma patients," said Josh Sommers, co-founder and executive director of the Chordoma Foundation .

Randall C. Starling, MD, MPH Receives 2023 HFSA Lifetime Achievement Award for His Contributions to the Field of Heart Failure

Retrieved on: 
목요일, 9월 14, 2023
Cleveland Clinic, Vice, University, Alpha and Omega, Heart failure, Education, Internal medicine, Temple University, Heart Failure Society of America, Lung transplantation, NIH, American College of Cardiology, Case Western Reserve University, Research, Journal of Cardiac Failure, Alpha Omega Alpha, National Institutes of Health, Associate, Bangladesh Technical Education Board, Science, OSU, University of Pittsburgh Medical Center, Public health, Journal, Publishing, Overmyer Network, Scientific programming language, Cardiology, Huntington Convention Center of Cleveland, Master, Biology, American College, MPH, Wilfrid Sellars, International Society, Medical device, Dentistry, MD, Medicine

The award will be presented to Dr. Starling at the HFSA Annual Scientific Meeting on Saturday, October 7 in Cleveland, Ohio.

Key Points: 
  • The award will be presented to Dr. Starling at the HFSA Annual Scientific Meeting on Saturday, October 7 in Cleveland, Ohio.
  • As an internationally recognized pioneer and expert in the field of heart failure, this prestigious award will pay tribute to his exemplary career in heart failure research, publishing, mentorship and leadership.
  • Dr. Starling served as President of HFSA in 2018-2019 and has been an active member since its inception in 1995.
  • Dr. Starling joins an elite list of current and past Lifetime Achievement Award winners with this year's recognition.

DreamLife Recovery Expands Pennsylvania Presence with Opening of PHP Outpatient Facility in Pittsburgh

Retrieved on: 
목요일, 9월 7, 2023
Insurance, Life, Aftercare, Hospital, Dream, PHP, Medical diagnosis, Patient, University of Pittsburgh Medical Center, Environment, Addiction, Nursing

PITTSBURGH, Sept. 7, 2023 /PRNewswire-PRWeb/ -- DreamLife Recovery, a Pennsylvania-based, clinician-owned facility that provides trauma-informed, comprehensive treatment for alcohol and drug addiction, announces the opening of its new partial hospitalization program (PHP) outpatient facility in Pittsburgh. Located at 107 Gamma Drive, Pittsburgh, PA 15238, the PHP facility provides structured and consistent care in a more flexible environment tailored to patients' lives, while extending the same level of care DreamLife Recovery is known for providing through its residential facility in nearby Donegal, Pennsylvania.

Key Points: 
  • PITTSBURGH, Sept. 7, 2023 /PRNewswire-PRWeb/ -- DreamLife Recovery , a Pennsylvania-based, clinician-owned facility that provides trauma-informed, comprehensive treatment for alcohol and drug addiction, announces the opening of its new partial hospitalization program (PHP) outpatient facility in Pittsburgh.
  • With the opening of this new facility, we are able to extend our care and help more individuals in our community achieve lasting recovery."
  • "The opening of our PHP facility in Pittsburgh is a significant milestone for DreamLife Recovery," said Lidice Morales, vice president of operations at DreamLife Recovery.
  • With on-site medical staff for comprehensive care and close collaboration with the residential facility, DreamLife Recovery Pittsburgh ensures each patient experiences a seamless continuum of treatment.